<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01862276</url>
  </required_header>
  <id_info>
    <org_study_id>KHBO1206</org_study_id>
    <secondary_id>UMIN000010416</secondary_id>
    <nct_id>NCT01862276</nct_id>
  </id_info>
  <brief_title>Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma</brief_title>
  <official_title>Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kansai Hepatobiliary Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kansai Hepatobiliary Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the prognosis due to presence or absence of bile duct resection in
      intrahepatic cholangiocarcinoma that require hepatic lobectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is
      still controversial. We retrospectively evaluated the effect of bile duct resection in this
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>3-year recurrence-free survival rate</measure>
    <time_frame>11 years (2000-2010)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ratio of local recurrence at the hepatico-duodenal ligament</measure>
    <time_frame>11 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Intrahepatic Cholangiocarcinoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who underwent hepatic lobectomy between 2000 and 2010 for intrahepatic
        cholangiocarcinoma, and did not undergo adjuvant chemotherapy will be included for
        analysis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cases of major hepatectomy due to intrahepatic cholangiocarcinoma

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hiroaki Nagano, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Osaka University Graduate School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Osaka University, Graduate School of Medicine</name>
      <address>
        <city>Osaka</city>
        <zip>565-0871</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2013</study_first_submitted>
  <study_first_submitted_qc>May 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2013</study_first_posted>
  <last_update_submitted>June 29, 2014</last_update_submitted>
  <last_update_submitted_qc>June 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

